Titrated mandibular advancement versus positive airway pressure for sleep apnoea by F. Gagnadoux et al.
Titrated mandibular advancement versus positive airway
pressure for sleep apnoea
Submitted by Emmanuel Lemoine on Wed, 12/11/2013 - 17:08
Titre Titrated mandibular advancement versus positive airway pressure for sleepapnoea
Type de
publication Article de revue
Auteur Gagnadoux, Frédéric [1], Fleury, B. [2], Vielle, Bruno [3], Pételle, B. [4], Meslier,Nicole [5], N’Guyen, X. L [6], Trzepizur, Wojciech [7], Racineux, Jean-Louis [8]
Pays Suisse
Editeur European Respiratory Society
Ville Lausanne





Pagination 914 - 920
Volume 34
Titre de la revue European Respiratory Journal
ISSN 1399-3003
Mots-clés Continuous Positive Airway Pressure [9], mandibular advancement [10],obstructive sleep apnoea [11], titration [12], treatment [13]
Résumé en
anglais
The aim of this study was to compare mandibular advancement device (MAd)
therapy and continuous positive airway pressure (CPAP) for obstructive sleep
apnoea/hypopnoea syndrome (OSAHS) after one-night polysomnographic (PSG)
titration of both treatments.
59 OSAHS patients (apnoea/hypopnoea index (AHI): 34±13 events·h−1; Epworth
scale: 10.6±4.5) were included in a crossover trial of 8 weeks of MAd and
8 weeks of CPAP after effective titration. Outcome measurements included home
sleep study, sleepiness, health-related quality of life (HRQoL), cognitive tests,
side-effects, compliance and preference.
The median (interquartile range) AHI was 2 (1–8) events·h−1 with CPAP and 6
(3–14) events·h−1 with MAd (p<0.001). Positive and negative predictive values of
MAd titration PSG for treatment success were 85% and 45%, respectively. Both
treatments significantly improved subjective and objective sleepiness, cognitive
tests and HRQoL. The reported compliance was higher for MAd (p<0.001) with
>70% of patients preferring this treatment.
These results support titrated MAd as an effective therapy in moderately sleepy
and overweight OSAHS patients. Although less effective than CPAP, successfully
titrated MAd was very effective at reducing the AHI and was associated with a
higher reported compliance. Both treatments improved functional outcomes to a
similar degree. One-night titration of MAd had a low negative predictive value for
treatment success.




















Publié sur Okina (http://okina.univ-angers.fr)
